Conditions: Hypertension
Keywords: Stage 1 Stage 2 Hypertension
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 641
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the efficacy, safety, and tolerability of 8 weeks of therapy with nebivolol in comparison to placebo in younger patients 18 - 54 years of age with stage 1 or stage 2 essential hypertension.

Detailed description:

Arms:
arm 1: Nebivolol (non-trade 5, 10 or 20 mg tablet), oral administration arm 2: Dose-matched placebo

Interventions: intervention 1: Nebivolol intervention 2: Placebo
Intervention descriptions: intervention 1: Nebivolol (non-trade 5, 10 or 20 mg tablet), oral administration intervention 2: Dose-match placebo

Protocol document: